Advertisement

Topics

Roivant Sciences Raises $1.1B to Fuel Creation of New Biotech Subsidiaries

14:00 EDT 11 Aug 2017 | Drug Discovery Development

Roivant focuses on developing and commercializing novel therapies through subsidiary 'Vants'.
Contributed Author: 
Roivant Sciences
Topics: 

Original Article: Roivant Sciences Raises $1.1B to Fuel Creation of New Biotech Subsidiaries

NEXT ARTICLE

More From BioPortfolio on "Roivant Sciences Raises $1.1B to Fuel Creation of New Biotech Subsidiaries"

Quick Search
Advertisement